Skip to main navigation
Investors
Alnylam
John M. Maraganore Ph.D.
Recent Press Releases
View all releases
May 11,2026
Summary Toggle
New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden
May 07,2026
Summary Toggle
Alnylam to Webcast Presentations at Upcoming Investor Conferences
May 04,2026
Summary Toggle
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM
View all releases
: (Common):
Price:
Change (%):
Volume:
Data as of
Copyright Refinitiv. Minimum 15 minutes delay
Learn More
